Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Total Non-Current Liabilities (2020 - 2025)

RxSight (RXST) has disclosed Total Non-Current Liabilities for 6 consecutive years, with $36.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Non-Current Liabilities rose 1.42% year-over-year to $36.1 million, compared with a TTM value of $36.1 million through Dec 2025, up 1.42%, and an annual FY2025 reading of $36.1 million, up 1.42% over the prior year.
  • Total Non-Current Liabilities was $36.1 million for Q4 2025 at RxSight, up from $32.6 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $60.3 million in Q4 2022 and bottomed at $19.2 million in Q1 2024.
  • Average Total Non-Current Liabilities over 5 years is $36.8 million, with a median of $33.7 million recorded in 2025.
  • The sharpest move saw Total Non-Current Liabilities crashed 63.3% in 2023, then soared 75.34% in 2025.
  • Year by year, Total Non-Current Liabilities stood at $54.5 million in 2021, then rose by 10.62% to $60.3 million in 2022, then plummeted by 63.3% to $22.1 million in 2023, then surged by 61.1% to $35.6 million in 2024, then rose by 1.42% to $36.1 million in 2025.
  • Business Quant data shows Total Non-Current Liabilities for RXST at $36.1 million in Q4 2025, $32.6 million in Q3 2025, and $31.0 million in Q2 2025.